OBJECTIVE: To explore the effects of clinical indicators, particularly thymectomy on the development of juvenile @entity1737 (JMG) through the developmental status of bone age (BA) and height. METHODS: A cross-sectional study of 80 JMG @entity1 was recruited to examine whether JMG @entity1 had the abnormalities of height and bone development according to the distribution of height standard deviation score (Ht @entity214 ) and BA. RESULTS: The mean BA was delayed by (0.15  1.32) years compared with @entity1 chronological age (CA). The mean Ht @entity214 (HtCA @entity214 -1.25  1.03) was also lower than healthy controls. In multivariate analysis, the age at onset was negatively associated with delayed BA (P=0.007) whereas the cumulative intake of @entity229 was negatively associated with HtCA @entity214 (P=0.043). No significant correlation existed between thymectomy and delayed BA or HtCA @entity214 . Delayed BA and slow growth existed in JMG @entity1 . The age at onset of JMG was a correlative factor for delayed BA. And the intake of cumulative @entity229 might be a determinant of @entity1032 . Thymectomy had no impact on the development of bone and height. CONCLUSION: We should pay more attention to monitoring BA and height in JMG @entity1 to take appropriate therapeutic interventions.

[Effects of thymectomy on bone age and height development in juvenile XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1032 :: ('MESH:D008607', 'Disease') :: ['height retardation'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity1737 :: ('MESH:D009157', 'Disease') :: ['myasthenia gravis'] @entity214 :: ('CHEBI:8984', 'Chemical') :: ['SDS']
@entity1737 :: (MESH:D009157,Disease) :: ['myasthenia gravis']
